AI-based methods are offering superhuman image enhancement. But their medical applications are not without risk – unless, that is, you consider a hybrid approach…
Author profile
ジョー コリガン
Head of Technology, Global Medical Technology
Joe brings products to market for drug delivery, diagnostics and minimally invasive surgery, having led the R&D of high risk (class 3) devices, including the regulatory approach and development of mechanical, electronic and software solutions, utilising the latest developments in Statistical Machine Learning, data science and Artificial Intelligence.
My insights
Digital biomarkers for patient-empowering connected health
The future promises a digitally connected healthcare system that empowers both patients and carers alike. So, what’s the next step for pharma companies and device developers with ambitions in the space?
No Results Found
The page you requested could not be found. Try refining your search, or use the navigation above to locate the post.